Clinical implications of the American Joint Committee on Cancer (AJCC) 8th edition update in seminoma pT1 subclassification

Mário Fontes-Sousa(Instituto Português de Oncologia Francisco Gentil), Maria Joaquina Maurício(IPO Porto), Rui Henrique(Universidade do Porto), Sância Ramos(Hospital Universitario Central de Asturias), João Lobo(Universidade do Porto), Ana Martins(Hospital de São João), João Cassis(Centro Hospitalar de Lisboa Ocidental), Mariana Malheiro(Centro Hospitalar de Lisboa Ocidental), Helena Magalhães(Hospital Pedro Hispano)
BMC Urology
August 20, 2020
10.1186/s12894-020-00682-7
Cited by 5

Related Papers

Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE
|Allergy|2004|1.1k
Integrative epigenetic taxonomy of primary prostate cancer
|Nature Communications|2018|167
Human Germ Cell Tumors are Developmental Cancers: Impact of Epigenetics on Pathobiology and Clinic
|International Journal of Molecular Sciences|2019|141
Application of miRNAs in the diagnosis and monitoring of testicular germ cell tumours
|Nature Reviews Urology|2020|112
<scp>WHO</scp> 2022 landscape of papillary and chromophobe renal cell carcinoma
|Histopathology|2022|112